2021
DOI: 10.1016/j.biopha.2021.111814
|View full text |Cite
|
Sign up to set email alerts
|

Pien-Tze-Huang, a Chinese patent formula, attenuates NLRP3 inflammasome-related neuroinflammation by enhancing autophagy via the AMPK/mTOR/ULK1 signaling pathway

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
19
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 42 publications
(19 citation statements)
references
References 39 publications
0
19
0
Order By: Relevance
“…Autophagy is regulated primarily by mTOR and AMPK, and a key regulator of autophagosome formation is ULK1. AMPK promotes autophagy by phosphorylating ULK1, whereas mTOR inhibits autophagy by inhibiting ULK1 phosphorylation [ 37 , 38 ]. AMPK-mediated inhibition of ULK1 involves two mechanisms: direct inhibition of phosphorylated ULK1 by AMPK and indirect inhibition of ULK1 phosphorylation by activating mTOR phosphorylation [ 39 , 40 , 41 ].…”
Section: Discussionmentioning
confidence: 99%
“…Autophagy is regulated primarily by mTOR and AMPK, and a key regulator of autophagosome formation is ULK1. AMPK promotes autophagy by phosphorylating ULK1, whereas mTOR inhibits autophagy by inhibiting ULK1 phosphorylation [ 37 , 38 ]. AMPK-mediated inhibition of ULK1 involves two mechanisms: direct inhibition of phosphorylated ULK1 by AMPK and indirect inhibition of ULK1 phosphorylation by activating mTOR phosphorylation [ 39 , 40 , 41 ].…”
Section: Discussionmentioning
confidence: 99%
“…Besides, enhanced microglial autophagy has been demonstrated to suppress the activation of NLRP3 inflammasome in LPS-treated BV2 microglia ( Espinosa-Garcia et al, 2020 ). Huang et al also verified that enhanced autophagy via AMPK/mTOR/ULK1 pathway could suppress NLRP3 inflammasome-mediated neuroinflammation in LPS-treated BV2 microglia ( Huang Z. et al, 2021 ). The therapeutic promise of inhibiting NLRP3 inflammasome activation by regulating microglial autophagy in cerebrovascular diseases has attracted increasing attention.…”
Section: Interaction Between Microglial Autophagy and Other Biologica...mentioning
confidence: 94%
“…Several intracellular molecules such as PARP14 (a member in the Poly (ADP-ribose) polymerase superfamily) and PGC-1α (peroxisome proliferator-activated receptor-γ coactivator-1α) have been demonstrated to limit microglial activation and promote neurological recovery after stroke by inducing microglial autophagy ( Han et al, 2021 ; Tang et al, 2021 ). Some drugs such as SB216763 (the serine/threonine kinase GSK-3β inhibitor) and Pien-Tze-Huang (a patent formula in the Chinese Pharmacopoeia for the treatment of inflammatory diseases) have also been found to suppress microglial over-activation and inflammatory response by inducing microglial autophagy in ischemic stroke ( Zhou et al, 2011 ; Huang Z. et al, 2021 ; Tang et al, 2021 ). Xia et al found that following OGD/R injury, blocking autophagic flux induced the transition of BV2 microglia toward a pro-inflammatory phenotype, which increases the release of proinflammatory cytokines and contributes to neuroinflammation ( Xia et al, 2016 ).…”
Section: Interaction Between Microglial Autophagy and Other Biologica...mentioning
confidence: 99%
“…DJ-1 interference combined with a Sirt1 inhibitor increased the effect of DJ-1 interference on microglial polarization from anti-inflammatory to pro-inflammatory states, decreased the level of the Atg5-Atg12-Atg16L1 complex, and inhibited autophagy during cerebral I/R injury (170). Activation of autophagy via the AMPK pathway could facilitate microglial anti-inflammatory activation and exert neuroprotective effects during an inflammatory process (171)(172)(173)(174)(175). P2X7 receptor can activate AMPK pathways in the regulation of mitochondrial and lysosomal functions in microglia (176,177).…”
Section: Microglia Autophagy Regulates Inflammatory Responses In Isch...mentioning
confidence: 99%